Cardiovascular Clinical Trials
Cardiovascular Disease
Not SpecifiedActive
Key Facts
About PanThera Bio
PanThera Bio is a private, London-based clinical research services company that accelerates clinical trials for pharmaceutical sponsors, primarily in oncology and immunology. It differentiates itself through a patient-centric recruitment model and claims to significantly reduce site activation and patient enrollment timelines compared to public sector benchmarks. The company is revenue-generating, operating as a service provider for clinical trial sponsors, and leverages its operational efficiency as a key value proposition.
View full company profileTherapeutic Areas
Other Cardiovascular Disease Drugs
| Drug | Company | Phase |
|---|---|---|
| Manocept Diagnostic | Navidea Biopharmaceuticals | Research |
| Undisclosed Therapeutic Program(s) | HeartcoR Solutions | Pre-clinical |
| Ramatroban (KAR101) | KARE Biosciences | Preclinical |
| Undisclosed Cardiovascular Device Program | Transluminal Technologies | Pre-clinical |
| iPSC-CM Cell Therapy | Khloris Biosciences | Research |
| Clinical Trial Integration | Aktiia | Various |
| Cardiovascular Disease Study | Arizona Research Center | Not Specified |
| Undisclosed | Zecardio Therapeutics | Discovery/Pre-clinical |
| HDL/LDL Regulation | Alpha-1 Biologics | Pre-clinical |
| Cardiovascular Program | Helixomer | Research |
| Undisclosed Cardiovascular Program | inQB8 Medical Technologies | Pre-clinical |
| Undisclosed Cardiovascular Program(s) | Salubris Biotherapeutics | Clinical-stage (phase unspecified) |